XML 34 R18.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Stock-Based Compensation | 12 Months Ended
--- | ---
Dec. 31, 2018
Stock-Based Compensation [Abstract] |
Stock-Based Compensation | ﻿ 10. STOCK-BASED COMPENSATION ﻿ At the 2005 annual meeting of stockholders, stockholders of the Company approved an equity incentive plan (as amended, the “2005 Plan”). The 2005 Plan expired in June 2015. There are options issued under the 2005 Plan that remain outstanding. The 2005 Plan provided for the grant of awards to eligible individuals in the form of stock, restricted stock, stock options, performance units or other stock-based awards, all as defined in the 2005 Plan. The 2005 Plan provided for the issuance of up to 2,000,000 shares of common stock to eligible individuals, including directors, through the various forms of permitted awards. The Company was not permitted to issue stock options at an exercise price lower than fair market value at the date of grant. All stock options were required to have an exercise period not to exceed ten years. The Company had granted awards of incentive stock options and non-qualified stock options under the 2005 Plan, all of which had exercise prices that were not less than the fair market value at the date of grant. Options granted had six-month, one-year, three-year or four-year vesting periods. All outstanding options were issued at market value as of the date of the grant. ﻿ Stockholders of the Company approved the 2016 Equity Incentive Plan (the “2016 Plan”) at the 2016 annual meeting of stockholders. The 2016 Plan will expire in June 2026. The 2016 Plan provides for the grant of awards to eligible individuals in the form of stock, restricted stock, stock options, performance units or other stock-based awards, all as defined in the 2016 Plan. The 2016 Plan provides for the issuance of up to 3,500,000 shares of common stock to eligible individuals, including directors, through the various forms of permitted awards. The Company is not permitted to issue stock options at an exercise price lower than fair market value at the date of grant. All stock options are required to have an exercise period not to exceed ten years. As of December 31, 2018, the Company has granted 308,970 target performance stock units (“PSUs”) under the 2016 Plan. Any committee as delegated by the board of directors has the power and discretion to, among other things, prescribe the terms and conditions for the exercise of, or modification of, any outstanding awards in the event of merger, acquisition or any other form of acquisition other than a reorganization of the Company under the United States Bankruptcy Code or liquidation of the Company. The 2016 Plan also allows limited transferability of any stock options to legal entities that are 100% owned or controlled by the optionee or to the optionee’s family trust. ﻿ PSUs The PSUs vest subject to market and performance conditions. The conditions are weighted 25% based on market conditions and 75% based on performance conditions. Market conditions are based on the Company’s total shareholder return (“TSR”) relative to a select group of peer companies at the end of a three-year performance period. Performance conditions are based on the Company’s actual Adjusted EBITDA over the three-year performance period compared to forecasted Adjusted EBITDA over the same period. Depending on the TSR and Adjusted EBITDA at the end of the performance period, anywhere from 0% to 200% of the target grant may vest. Expense is recognized on a straight-line basis over the performance period beginning on the date of grant. Probability is assessed quarterly on the performance conditions and compensation expense is adjusted accordingly. Actual forfeitures are recognized as they occur. ﻿ Activity in the Company’s stock-based compensation plan for the PSUs was as follows: ﻿
﻿ |  |  |  |  |
﻿ |  | Target PSUs |  |  | Weighted-Average Grant-Date Fair Value
﻿Nonvested at January 1, 2017 |  | — |  | $ | —
﻿Granted |  | 167,968 |  |  | 8.03
﻿Vested |  | — |  |  | —
﻿Forfeited |  | — |  |  | —
﻿Nonvested at December 31, 2017 |  | 167,968 |  | $ | 8.03
﻿Granted |  | 141,002 |  |  | 11.97
﻿Vested |  | — |  |  | —
﻿Forfeited |  | — |  |  | —
﻿Nonvested at December 31, 2018 |  | 308,970 |  | $ | 9.83
﻿ At December 31, 2018, there was a total of $1.7 million of total unrecognized compensation expense related to the PSUs. The cost is expected to be recognized over a weighted-average period of 1.8 years. ﻿ The fair value of the PSUs granted is estimated on the date of grant using the Monte Carlo model with the following assumptions: ﻿ ﻿
﻿ |  |
﻿Assumptions for PSU Awards |  |
﻿ | 2018 | 2017
﻿Risk-free interest rate | 2.61% | 1.59%
﻿Expected life | 2.7 years | 3.0 years
﻿Expected volatility | 34.7% | 36.50%
﻿Expected dividends | $0 | $0
﻿Forfeiture rate | 0% | 0%
﻿ ﻿ Stock Options Activity related to options in the Company’s stock-based compensation plans for employee stock options was as follows: ﻿ ﻿ ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  | Option Shares |  |  | Weighted-Average Exercise Price |  | Weighted-Average Remaining Contractual Term (1) |  | Options Exercisable |  |  | Weighted-Average Exercise Price
﻿Outstanding at January 1, 2018 |  | 1,276,411 |  | $ | 4.98 |  | 6.88 |  | 1,276,411 |  | $ | 4.98
﻿Granted |  | — |  |  | — |  |  |  |  |  |  |
﻿Exercised |  | (41,411) |  |  | 3.87 |  |  |  |  |  |  |
﻿Cancelled or forfeited |  | — |  |  | — |  |  |  |  |  |  |
﻿Expired |  | — |  |  | — |  |  |  |  |  |  |
﻿Outstanding at December 31, 2018 |  | 1,235,000 |  | $ | 5.02 |  | 5.94 |  | 1,235,000 |  | $ | 5.02
﻿(1) In years |  |  |  |  |  |  |  |  |  |  |  |
﻿ As of December 31, 2018, there were 31,700 options outstanding to independent directors of the Company with a weighted-average exercise price of $5.10. At December 31, 2018, there was no unrecognized compensation expense. ﻿ The following table summarizes information about employee stock options outstanding and exercisable at December 31, 2018: ﻿ ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Dollar amounts in thousands |  | Options Outstanding |  | Options Exercisable |  |  | Intrinsic Value of Options Outstanding |  |  | Intrinsic Value of Options Exercisable |  | Weighted-Average Life of Options Outstanding (1) |  | Weighted-Average Life of Options Exercisable (1)
﻿Exercise Price: |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿$2.30 |  | 15,000 |  | 15,000 |  | $ | 76 |  | $ | 76 |  | 1.4 |  | 1.4
﻿$5.05 |  | 1,220,000 |  | 1,220,000 |  |  | 2,855 |  |  | 2,855 |  | 6.0 |  | 6.0
﻿ |  | 1,235,000 |  | 1,235,000 |  | $ | 2,931 |  | $ | 2,931 |  | 5.9 |  | 5.9
﻿(1) In years |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |
The aggregate intrinsic value represents the difference between the Company’s closing stock price of $7.39 per share as of December 31, 2018 and the exercise price multiplied by the number of options outstanding or exercisable as of that date. ﻿ Activity in the Company’s stock-based compensation plan for nonvested employee stock options was as follows: ﻿ ﻿
﻿ |  |  |  |  |
﻿ |  | Options |  |  | Weighted-Average Grant Date Fair Value
﻿Nonvested at January 1, 2016 |  | 682,500 |  | $ | 2.55
﻿Granted |  | — |  |  | —
﻿Vested |  | (335,000) |  |  | 2.55
﻿Forfeited |  | (12,500) |  |  | 2.55
﻿Nonvested at December 31, 2016 |  | 335,000 |  | $ | 2.55
﻿Granted |  | — |  |  | —
﻿Vested |  | (331,250) |  |  | 2.55
﻿Forfeited |  | (3,750) |  |  | 2.55
﻿Nonvested at December 31, 2017 |  | — |  | $ | —
﻿ |  |  |  |  |
In addition, 18,750 options granted to the Company’s independent directors vested during the year ended December 31, 2017. The total fair value of options vested was $0.9 million and $1.1 million for the years ended December 31, 2017 and 2016, respectively. All options for employees and directors were fully vested as of December 31, 2017. No additional options were issued during the year ended December 31, 2018. ﻿ The following table includes additional information related to cash exercises of stock options: ﻿
﻿ |  |  |  |  |  |  |  |  |
﻿ |  | For the Year Ended December 31,
﻿Amounts in thousands |  | 2018 |  | 2017 |  | 2016
﻿Intrinsic value of share-based awards exercised |  | $ | 298 |  | $ | 16 |  | $ | 28
﻿ The intrinsic value of options exercised through net share settlement was less than $0.1 million for the year ended December 31, 2018. The tax benefit from option exercises was $0.1 million for the year ended December 31, 2018. ﻿ Stock-based compensation expense was recognized in general and administrative expenses on the Company’s consolidated statement of earnings as follows: ﻿
﻿ |  |  |  |  |  |  |  |  |
﻿ |  | For the Year Ended December 31,
﻿Amounts in thousands |  | 2018 |  | 2017 |  | 2016
﻿Compensation cost: |  |  |  |  |  |  |  |  |
﻿2005 Plan |  | $ | — |  | $ | 277 |  | $ | 759
﻿2016 Plan |  |  | 868 |  |  | 392 |  |  | —
﻿Total compensation cost |  | $ | 868 |  | $ | 669 |  | $ | 759
﻿ |  |  |  |  |  |  |  |  |
﻿

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration